Skip to search formSkip to main contentSkip to account menu

azinomycin B

Known as: 1-Naphthalenecarboxylic acid, 3-methoxy-5-methyl-, 2-((1-(3-(acetyloxy)-4-hydroxy-1-azabicyclo(3.1.0)hex-2-ylidene)-2-((1-(hydroxymethylene)-2-oxopropyl)amino)-2-oxoethyl)amino)-1-(2-methyloxiranyl)-2-oxoethyl ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The biosynthesis of the azinomycins involves the conversion of glutamic acid to an aziridino[1,2-a]pyrrolidine moiety, which… 
2017
2017
To explore the utility of the azinomycin B chromophore as a platform for the development of major-groove binding small molecules… 
2012
2012
AbstractAzinomycin B—a well-known antitumor drug—forms cross-links with DNA through alkylation of purine bases and blocks tumor… 
2011
2011
A protein identified from the Streptomyces sahachiroi genome exhibits a protective effect against the DNA alkylator azinomycin B… 
2007
2007
Evaluation of the importance of C18/C19 stereochemistry of azinomycin A/B epoxyamide partial structures with respect to DNA… 
Review
2006
Review
2006
.................................................................................................. Dedication… 
2005
2005
In this work, we present molecular modeling studies carried out using six DNA sequences and six azinomycin analogues, including… 
2004
2004
13C-labelled acetate efficiently labels the antitumour natural product azinomycin B, revealing a polyketide origin for the… 
2002
2002
A new set of charges specifically developed for biologically relevant N7-alkylated purine adducts have been implemented in the…